Search results
NanoViricides to Participate in the 2024 EF Hutton Annual Global Conference On May 15 in New York...
Morningstar· 5 days agoSHELTON, CT / ACCESSWIRE / May 10, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a global leader in broad-spectrum antiviral nanomedicines, today announces that Anil R. Diwan ...
Judge dismisses lawsuit over Iowa ending COVID benefits early
Sioux City Journal· 4 days agoA U.S. District Court judge on Friday dismissed a class-action lawsuit over Iowa Gov. Kim Reynolds’...
NanoViricides to Participate in the 2024 EF Hutton Annual Global Conference On May 15 in New York...
Digital Journal· 5 days agoSHELTON, CT / ACCESSWIRE / May 10, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a global leader in broad-spectrum antiviral nanomedicines, today announces that Anil R. Diwan ...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 2 days agoPositive results from Phase 1 norovirus study in lactating mothers indicate the potential of Vaxart’s oral pill vaccine candidate to protect or reduce the effect of the disease in infants Expects to initiate Phase 2b study evaluating Vaxart
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Receives $50.80 Average Target Price from Brokerages
ETF DAILY NEWS· 4 days agoFree Report) has been given an average recommendation of “Moderate Buy” by the eleven brokerages that are presently covering the stock, MarketBeat.com reports. The average 1 year target price ...
A Novel Broad-Spectrum Antiviral with Activity Against Smallpox/Mpox
Digital Journal· 7 days agoSHELTON, CT / ACCESSWIRE / May 8, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a global leader in broad-spectrum antiviral nanomedicines, says that the ultra-broad antiviral ...